Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-27

Clinical Trial Update: Investigation of Efficacy and Tolerability of WO 2707, a MoistCream Cremolum, in Postmenopausal Women Suffering From Symptoms of Vaginal Dryness [Phase 4]

View source ↗

Summary

Phase 4 trial update on WO 2707 moist cream (Cremolum) for vaginal dryness in postmenopausal women with vaginal atrophy; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • WO 2707 MoistCream Cremolum (WO 2707 MoistCream Cremolum)

Snippet

Sponsor: Dr. August Wolff GmbH & Co. KG Arzneimittel | Conditions: Vaginal Atrophy | Phase 4 | Status: COMPLETED